We are live on ! Find out more
MCM

Matterhorn Capital Management Portfolio holdings

AUM $151M
1-Year Est. Return 14.72%
This Fund
S&P 500
This Quarter Est. Return
+4.21%
1 Year Est. Return
+14.72%
3 Year Est. Return
+38.83%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$219M
AUM Growth
+$11.4M
Cap. Flow
+$6.33M
Cap. Flow %
2.89%
Top 10 Hldgs %
30.3%
Holding
58
New
5
Increased
35
Reduced
6
Closed
10

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$6.23M
2
MSFT icon
Microsoft
MSFT
+$5.2M
3
SBNY
Signature Bank
SBNY
+$3.93M
4
EXPD icon
Expeditors International
EXPD
+$3.67M
5
BIIB icon
Biogen
BIIB
+$3.57M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$6.96M
2
CF icon
CF Industries
CF
+$5.17M
3
HPQ icon
HP
HPQ
+$4.08M
4
WAB icon
Wabtec
WAB
+$3.35M
5
MIDD icon
Middleby
MIDD
+$3.32M

Sector Composition

Rank Sector Weight
1 Financials 26.11%
2 Healthcare 23.01%
3 Technology 21.15%
4 Communication Services 7.41%
5 Energy 5.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CELG
26
DELISTED
Celgene Corp
CELG
$4.01M 1.83%
33,469
+4,655
+16% +$539K
SBNY
27
DELISTED
Signature Bank
SBNY
$4M 1.83%
+26,049
New +$3.93M
AAPL icon
28
Apple
AAPL
$4.56T
$3.97M 1.81%
150,844
+17,448
+13% +$499K
GILD icon
29
Gilead Sciences
GILD
$162B
$3.82M 1.74%
37,738
+4,974
+15% +$518K
BIIB icon
30
Biogen
BIIB
$30B
$3.81M 1.74%
+12,427
New +$3.57M
CTSH icon
31
Cognizant
CTSH
$24.8B
$3.73M 1.7%
62,066
+7,874
+15% +$507K
PFE icon
32
Pfizer
PFE
$148B
$3.7M 1.69%
120,766
+15,486
+15% +$487K
SLB icon
33
SLB Ltd
SLB
$76.4B
$3.69M 1.69%
52,945
+16,131
+44% +$1.21M
MCK icon
34
McKesson
MCK
$99.3B
$3.66M 1.67%
18,537
+3,718
+25% +$702K
FFIV icon
35
F5
FFIV
$23.5B
$3.58M 1.64%
36,941
+10,678
+41% +$1.15M
EXPD icon
36
Expeditors International
EXPD
$23B
$3.42M 1.56%
+75,790
New +$3.67M
ALV icon
37
Autoliv
ALV
$8.93B
$3.33M 1.52%
37,029
+119
+0.3% +$10.4K
UL icon
38
Unilever
UL
$137B
$3.28M 1.5%
67,549
-378
-0.6% -$18.4K
SNBR
39
DELISTED
Sleep Number
SNBR
$3.26M 1.49%
152,240
+21,215
+16% +$486K
TSM icon
40
TSMC
TSM
$2.18T
$3.25M 1.49%
142,940
+1,759
+1% +$39.6K
NVS icon
41
Novartis
NVS
$293B
$3.09M 1.41%
40,111
-16
-0% -$1.27K
RDS.A
42
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$2.92M 1.33%
67,225
-1,143
-2% -$54.4K
SHPG
43
DELISTED
Shire pic
SHPG
$2.9M 1.33%
14,168
+104
+0.7% +$21.6K
SMFG icon
44
Sumitomo Mitsui Financial
SMFG
$164B
$2.85M 1.3%
375,802
-3,195
-0.8% -$25.1K
ASML icon
45
ASML
ASML
$662B
$2.8M 1.28%
31,582
+303
+1% +$27.6K
BCS icon
46
Barclays
BCS
$96.4B
$2.62M 1.19%
215,289
-1,483
-0.7% -$19.7K
PB icon
47
Prosperity Bancshares
PB
$8.93B
$2.25M 1.03%
47,000
– –
BNS icon
48
Scotiabank
BNS
$108B
$2.17M 0.99%
54,858
-824
-1% -$35.6K
BLK icon
49
Blackrock
BLK
$175B
– –
-10,290
Closed -$3.06M
CF icon
50
CF Industries
CF
$17.4B
– –
-115,227
Closed -$5.17M
1
2
3

Similar funds

DCM
Destrier Capital Management New York $144M AUM 7.28% 1-Year Est. Return
WRM
Westport Resources Management Westport, Connecticut $138M AUM 14.6% 1-Year Est. Return
SLCM
Seven Locks Capital Management New York $168M AUM 17.91% 1-Year Est. Return
AC
Alpenglow Capital San Carlos, California $126M AUM 13.04% 1-Year Est. Return
MI
Montage Investments Leawood, Kansas $182M AUM 18.14% 1-Year Est. Return
EDRM
Edmond de Rothschild (Monaco) Monaco $116M AUM
SVGI
Sapphire Ventures (GPE) I Palo Alto, California $115M AUM 11.63% 1-Year Est. Return
SAMNY
Samsung Asset Management (New York) New York $109M AUM 14.33% 1-Year Est. Return

Matterhorn Capital Management's Q4 2015 Portfolio in Review

As of Q4 2015, Matterhorn Capital Management held 58 positions worth $219M, up 5.5% from $207M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Matterhorn Capital Management's Q4 2015 filing shows 5 new, 35 increased, 6 reduced and 10 closed positions. Its largest new stake was Merck: 123,488 shares worth $6.22M. The largest sale was Eli Lilly, an estimated $6.96M.

By sector, the portfolio is most concentrated in Financials at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Technology.

  • Matterhorn Capital Management's largest Q4 2015 buy was Merck: 123,488 shares worth $6.22M.
  • Matterhorn Capital Management added most to Criteo S.A. Ordinary Shares in Q4 2015, an estimated $1.71M increase.
  • Matterhorn Capital Management's biggest Q4 2015 reduction was Royal Dutch Shell PLC ADS Class A, cutting an estimated $54.4K.
  • Matterhorn Capital Management fully exited Eli Lilly in Q4 2015, selling an estimated $6.96M.
  • Matterhorn Capital Management's ten largest holdings make up 30% of its $219M portfolio in Q4 2015.
  • Matterhorn Capital Management opened 5 new positions and closed 10 in Q4 2015.
  • Matterhorn Capital Management's portfolio value rose 5.5% quarter-over-quarter to $219M.

Based on Matterhorn Capital Management's 13F filing for Q4 2015, filed 2 Feb 2016.